Ulinastatin showed a significant effect on inflammatory markers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), as well as reduced and prevented MODS and lowered mortality in AP [15,16]. The gene discussed is IL6; the disease is alkaline phosphatase measurement.